Cardiovascular Systems

Selected news for the company - Cardiovascular Systems, collected since 10/2017. Recent stories appear in theenterpriseleader.com and wkrb13.com. This company shares news with Tactile Systems Technology, Medtronic, Terumo, Zimmer Biomet and dozens of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
7/26/2021 Cardiovascular Systems (NASDAQ:CSII) Given a $38.75 Price Target by SVB Leerink Analysts thelincolnianonline.com SVB Leerink set a $38.75 price target on Cardiovascular Systems (NASDAQ:CSII) in a research report sent to investors on Friday morning, Analyst Ratings Network reports. The brokerage currently has a buy rating on the medical device company’s stock. Several other equities research analysts have also recently commented on the stock. Barclays assumed coverage on shares of Cardiovascular Systems in a research report on Monday, May 24th. They set ...
7/26/2021 SVB Leerink Analysts Give Cardiovascular Systems (NASDAQ:CSII) a $38.75 Price Target com-unik.info SVB Leerink set a $38.75 price objective on Cardiovascular Systems (NASDAQ:CSII) in a report released on Friday morning, Price Targets.com reports. The firm currently has a buy rating on the medical device company’s stock. CSII has been the subject of a number of other reports. Barclays started coverage on shares of Cardiovascular Systems in a report on Monday, May 24th. They set an equal weight rating and a ...
7/20/2021 SG Americas Securities LLC Takes Position in Cardiovascular Systems, Inc. (NASDAQ:CSII) theenterpriseleader.com SG Americas Securities LLC purchased a new stake in shares of Cardiovascular Systems, Inc. (NASDAQ:CSII) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,881 shares of the medical device company’s stock, valued at approximately $187,000. Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company ...
7/20/2021 Cardiovascular Systems (NASDAQ:CSII) and Delcath Systems (NASDAQ:DCTH) Critical Survey - WKRB News wkrb13.com ... small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, risk, profitability and valuation.ProfitabilityGet Cardiovascular Systems alerts: This table compares Cardiovascular Systems and Delcath Systems’ net margins, return on equity and return on assets.Net Margins Return on Equity Return on Assets Cardiovascular Systems -10.11% -8.62% -6.77% Delcath Systems ...
7/20/2021 Cardiovascular Systems (NASDAQ:CSII) versus Delcath Systems (NASDAQ:DCTH) Head-To-Head Survey zolmax.com ... cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ownership, valuation, risk and earnings. Risk and Volatility Cardiovascular Systems has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500. Comparatively, Delcath Systems has a beta of 0.56, indicating that its stock price is 44 ...
7/20/2021 Cardiovascular Systems’ (CSII) “Buy” Rating Reiterated at Northland Securities - WKRB News wkrb13.com Northland Securities restated their buy rating on shares of Cardiovascular Systems (NASDAQ:CSII) in a report issued on Friday morning, TipRanks reports. Northland Securities currently has a $45.00 target price on the medical device company’s stock.A number of other brokerages have also weighed in on CSII. TheStreet lowered Cardiovascular Systems from a c rating to a d+ rating in a report on Tuesday, May 11th. Barclays initiated coverage ...
7/20/2021 Cardiovascular Systems’ (CSII) “Buy” Rating Reiterated at Northland Securities rivertonroll.com Northland Securities restated their buy rating on shares of Cardiovascular Systems (NASDAQ:CSII) in a research report report published on Friday morning, TipRanks reports. The firm currently has a $45.00 target price on the medical device company’s stock. A number of other equities analysts have also recently weighed in on the company. Barclays assumed coverage on Cardiovascular Systems in a report on Monday, May 24th. They issued an equal ...
7/20/2021 4,881 Shares in Cardiovascular Systems, Inc. (NASDAQ:CSII) Acquired by SG Americas Securities LLC - Transcript Daily transcriptdaily.com SG Americas Securities LLC acquired a new position in shares of Cardiovascular Systems, Inc. (NASDAQ:CSII) in the first quarter, HoldingsChannel.com reports. The institutional investor acquired 4,881 shares of the medical device company’s stock, valued at approximately $187,000.A number of other hedge funds also recently added to or reduced their stakes in the stock. Altshuler Shaham Ltd acquired a new position in Cardiovascular Systems in the 1st quarter ...
7/20/2021 UBS Asset Management Americas Inc. Has $1.48 Million Holdings in Cardiovascular Systems, Inc. (NASDAQ:CSII) rivertonroll.com UBS Asset Management Americas Inc. increased its stake in Cardiovascular Systems, Inc. (NASDAQ:CSII) by 2.1% in the first quarter, Holdings Channel.com reports. The firm owned 38,696 shares of the medical device company’s stock after purchasing an additional 802 shares during the quarter. UBS Asset Management Americas Inc.’s holdings in Cardiovascular Systems were worth $1,484,000 as of its most recent SEC filing. A number of other hedge funds ...
7/20/2021 Cardiovascular Systems, Inc. (NASDAQ:CSII) Shares Purchased by UBS Asset Management Americas Inc. slatersentinel.com UBS Asset Management Americas Inc. raised its position in shares of Cardiovascular Systems , Inc. (NASDAQ:CSII) by 2.1% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 38,696 shares of the medical device company’s stock after purchasing an additional 802 shares during the quarter. UBS Asset Management Americas Inc. owned about 0.10% of Cardiovascular Systems worth $1,484,000 ...
6/29/2021 Haemonetics (HAE) Receives a Buy from Needham analystratings.com ... 68.06. According to TipRanks.com , Matson is a 5-star analyst with an average return of 18.6% and a 71.9% success rate. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Cardiovascular Systems , and Zimmer Biomet Holdings. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Haemonetics with a $80.33 average price target, implying a 22.1% upside from current levels. In ...
6/8/2021 Peregrine Capital Management LLC Buys 5,213 Shares of Cardiovascular Systems, Inc. (NASDAQ:CSII) baseballnewssource.com Peregrine Capital Management LLC Buys 5,213 Shares of Cardiovascular Systems, Inc. (NASDAQ:CSII) Posted by Don Miller on Jun 8th, 2021 Share on StocktwitsPeregrine Capital Management LLC lifted its stake in Cardiovascular Systems, Inc. (NASDAQ:CSII) by 1.4% during the first quarter, HoldingsChannel reports. The firm owned 374,722 shares of the medical device company’s stock after purchasing an additional 5,213 shares during the period. Peregrine Capital Management LLC ...
6/7/2021 Needham Sticks to Their Hold Rating for LivaNova (LIVN) analystratings.com ... Matson is a 5-star analyst with an average return of 15.8% and a 67.3% success rate. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Zimmer Biomet Holdings, and Cardiovascular Systems .Currently, the analyst consensus on LivaNova is a Moderate Buy with an average price target of $96.60.The company has a one-year high of $90.25 and a one-year low of $41.07. Currently ...